Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study - Concepedia

Concepedia

Publication | Open Access

Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study

DOI Full Paper Access

31

Citations

32

References

2021

Year

Hui Li, Shukui Qin, Ying Liu, Zhendong Chen, Zhenggang Ren, Jianping Xiong, Zhiqiang Meng, Xiao Zhang, Linna Wang, Xiaojing Zhang,

Drug Design Development and Therapy

Abstract

Camrelizumab combined with FOLFOX4 for first-line treatment of patients with aHCC showed good safety and tolerability, with promising preliminary antitumor activity.

References

	Year	Citations

Page 1